Back to search

Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).

Tetsuhiko Nomura, Hitoshi Hasegawa
PubMed

Data up to Jan 2025

Published2000
Citations16
References0
Fields
BiologyCancer researchImmunology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine… (2000) – PubMed | Metascience Observatory Explorer